Psychemedics (Psychemedics) Change In Working Capital : $-1.73 Mil (TTM As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Psychemedics Change In Working Capital?

Psychemedics's change in working capital for the quarter that ended in Dec. 2023 was $0.72 Mil.

Psychemedics's change in working capital for the fiscal year that ended in Dec. 2023 was $-1.73 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Psychemedics Change In Working Capital Historical Data

The historical data trend for Psychemedics's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psychemedics Change In Working Capital Chart

Psychemedics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-0.53

-4.17

-0.80

2.32

-1.73

Psychemedics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital	Get a 7-Day Free Trial															1.40	-0.73	-0.48	-1.24	0.72

Psychemedics Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.73 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Psychemedics Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Psychemedics's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Psychemedics (Psychemedics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psychemedics Corp (NAS:PMD) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

289 Great Road, Suite 200, Acton, MA, USA, 01720

Website

https://www.psychemedics.com

Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. Geographically it generates the majority of its revenue from the United States.

Executives

Shannon Shoemaker	officer: Chief Revenue Officer	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Charles M Doucot	officer: Executive Vice President	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Andrew Reynolds	director	C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Brian Hullinger	director, officer: President & CEO	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Robyn C Davis	director	ONE WALLINGFORD ROAD, MARBLEHEAD MA 01945
Michael Weisenhoff	other: Assistant Controller	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Michael I Schaffer	officer: VP of Laboratory Operations	C/O PAYCHEMEDICS CORP, 1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138
William B. Norris	other: Assistant Controller	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Darius G Nevin	other: See Footnote 1	C/O WCI COMMUNITIES, INC., 24301 WALDEN CENTER DRIVE, BONITA SPRINGS FL 34134
Peter H Kamin	10 percent owner	2720 DONALD ROSS ROAD, #311, PALM BEACH GARDENS FL 33410
Andrew Limbek	officer: Vice President & Controller	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Fred J Weinert	director	330 E MAIN ST, BARRINGTON IL 60620
Kubacki Raymond C Jr	director, officer: Chairman, CEO & President	125 NAGOG PARK, ACTON MA 01720
A Clinton Allen	director, officer: Chairman	1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138
Neil Lerner	officer: VP - Finance	C/O PSYCHEMEDICS CORPORATION, 125 NAGOG PARK, ACTON MA 01720